Nancy Denyes - Jun 5, 2024 Form 4 Insider Report for aTYR PHARMA INC (ATYR)

Role
General Counsel
Signature
/s/ Nancy E. Denyes
Stock symbol
ATYR
Transactions as of
Jun 5, 2024
Transactions value $
$9,276
Form type
4
Date filed
6/6/2024, 08:26 AM
Previous filing
Feb 6, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATYR Common Stock Purchase $9.28K +5K +28.96% $1.86 22.3K Jun 5, 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents weighted average price for the shares. The shares were purchased at prices ranging from $1.835 to $1.87 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.
F2 Includes 2,500 shares acquired on May 15, 2024 under the Company's 2015 Employee Purchase Plan.